StockTipsArenaBeta

BUY Torrent Pharmaceuticals Limited — Somil Mehta, Sharekhan

BUYTorrent Pharmaceuticals Limited

bySomil Mehta, SharekhanHorizon: NA (inferred 1–3 months)28 Aug 2026via CNBC Awaaz.

Entry₹5,048Inferred
Target₹5,400
Total upside +6.97% (call closed)
Stop loss₹4,850-3.92% risk
Exit₹4,8504 Sept 2026, 12:09 pm
Stop-loss hit-3.92%
Follow Somil Mehta for new calls(38% target hit, 42 closed calls)Get alertsWatch TORNTPHARM for new buy/sell callsGet alertsSee 16 active Short-term picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 7 Sept, 9:49 pm IST
9 supporting3 neutral0 opposing
Supports the BUY call (9)

Torrent Pharma Plans Drug Discovery Return After Decade of M&A

NewsGoogle News·22 Aug · 2w ago

(opens in new tab)

Torrent Pharma Share Price: 10 साल बाद कंपनी का बड़ा फैसला! दवा रिसर्च में वापसी, क्या निवेशकों को होगा फायदा?

NewsGoogle News·22 Aug · 2w ago

(opens in new tab)

Ruby Mills sells The Ruby 33rd floor to Torrent Pharma for ₹124.08 crore

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)

Ruby Mills शेयर में ₹124 करोड़ का बड़ा निवेश! कंपनी ने बिल्डिंग का हिस्सा बेचा

NewsGoogle News·20 Aug · 2w ago

(opens in new tab)

4 advisors have active long-term BUY calls on this stock

Advisor consensus · adjacent horizon·19 Aug · 2w ago

Neutral / worth noting (3)

Torrent Pharma Share: Q1 முடிவுகள்! வருவாய் ஜோர், லாபம் மிதமோ?

NewsGoogle News·17 Aug · 2w ago

(opens in new tab)

Torrent Pharma assigned ESG rating of 70 by NSE Sustainability

NewsGoogle News·11 Aug · 3w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.